Finance

Beta
Lists
IOF:LON
Iofina plc
GBX 49.00
-1.01%
(-0.50) 1D
Jun 30, 4:46:59 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for IOF...
Open
GBX 49.00
High
GBX 51.00
Low
GBX 48.00
Mkt. cap
93.94M
Avg. vol.
539.19K
Volume
261.24K
P/E ratio
15.77
52-wk high
GBX 59.00
52-wk low
GBX 20.00
EPS
GBX 0.03
Shares outstanding
191.86M
No. of employees
126
Open
GBX 49.00
High
GBX 51.00
Low
GBX 48.00
Mkt. cap
93.94M
Avg. vol.
539.19K
Volume
261.24K
P/E ratio
15.77
52-wk high
GBX 59.00
52-wk low
GBX 20.00
EPS
GBX 0.03
Shares outstanding
191.86M
No. of employees
126
News stories
From sources across the web
Profile
Iofina plc is a US based vertically integrated company that specializes in the exploration and production of iodine and the manufacturing of specialty chemical derivatives. It markets around the globe via its business lines, Iofina Resources and Iofina Chemical. Iofina Resources is the group's iodine production business, which isolates iodine using its proprietary WET IOsorb technologies. It isolates iodine recovered from brine produced from oil and gas operations that would otherwise be wasted. It is the second-largest producer of iodine in North America, which currently imports the vast majority of its iodine. Iodine has numerous applications in human health, biocides, the manufacture of acetic, and many other areas. IR's iodine is either sold directly to global customers or converted to iodine-based compounds at its sister company, Iofina Chemical. Iofina Chemical is the group's halogen-based specialty chemical producer. IC has invested heavily in researching and developing new iodo-, chloro-, and fluoro-based specialty compounds and provides the global market with quality iodine products. Wikipedia
About Iofina plc
CEO-
Employees126
Founded2005
Headquarters-
SectorSpeciality chemicals
Websiteiofina.com
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
14.58M
14.58M
18.67M
18.67M
Cost of goods sold
11.42M
11.42M
12.82M
12.82M
Cost of revenue
11.42M
11.42M
12.82M
12.82M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.52M
1.52M
1.59M
1.59M
Operating expense
2.28M
2.28M
2.40M
2.40M
Total operating expenses
13.70M
13.70M
15.21M
15.21M
Operating income
882.00K
882.00K
3.46M
3.46M
Other non operating income
-
-
-
-
EBT including unusual items
1.73M
1.73M
3.53M
3.53M
EBT excluding unusual items
828.00K
828.00K
3.40M
3.40M
Income tax expense
478.00K
478.00K
851.00K
851.00K
Effective tax rate
27.60%
27.60%
24.10%
24.10%
Other operating expenses
-
-
-
-
Net income
1.25M
1.25M
2.68M
2.68M
Net profit margin
8.60%
8.60%
14.35%
14.35%
Earnings per share
-
-
-
-
Interest and investment income
18.00K
18.00K
52.50K
52.50K
Interest expense
-72.00K
-72.00K
-116.00K
-116.00K
Net interest expenses
-54.00K
-54.00K
-63.50K
-63.50K
Depreciation and amortization charges
756.50K
756.50K
808.50K
808.50K
EBITDA
1.64M
1.64M
4.22M
4.22M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer